+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Genomics Market by Product & Service (System & Software, Consumables, Services), Technology (Sequencing, PCR), Application (Drug Discovery & Development, Diagnostic, Agriculture), End-user (Hospital & Clinics, Research Centers), and Region - Forecast to 2025

  • ID: 5275027
  • Report
  • February 2021
  • Region: Global
  • 192 Pages
  • Markets and Markets
Global Genomics Market is Projected to Reach US$ 54.4 Billion by 2025 from US$ 22.7 Billion in 2020, Rising at a CAGR of 19%

FEATURED COMPANIES

  • 23Andme, Inc.
  • BGI
  • Danaher Corporation
  • Eurofins Scientific
  • Illumina, Inc.
  • New England Biolabs
  • MORE

The global genomics market is projected to reach USD 54.4 billion by 2025 from USD 22.7 billion in 2020, at a CAGR of 19% during the forecast period.

The major factors driving the growth of this market include the increasing government funding to support genomics projects, the growing incidence of cancer and increasing applications of NGS in cancer research, the entry of new players and start-ups in the genomics market, and the growing application areas of genomics.

By product segment, the consumables accounted for the fastest growing segment of the genomics market

Based on product & service, the genomics market is segmented into consumables, systems & software, and services. In 2019, consumables accounted for the fastest growing segment of the genomics market during the forecast period. Consumables are used in large numbers in genomic systems, and their use will continue to increase with the growing number of genomic tests performed across the globe. This is a key factor driving the market growth.

By application, the drug discovery and development segment accounted for the largest share of the genomics market

Based on application, the genomics market is segmented into drug discovery and development, diagnostics, agriculture and animal research, and other applications. Drug discovery and development accounted for the largest application segment in the genomics market in 2019. The large share of this segment can be attributed to the increasing research on diseases such as cancer and genetic disorders and the decreasing cost of sequencing.

Asia-Pacific: The fastest-growing region in the genomics market

The genomics market in the Asia-Pacific is projected to register the highest growth during the forecast period, mainly due to favorable government support for genomics projects, increasing awareness about newer genomics technologies such as NGS, and expansions of key players to strengthen their presence in the APAC region.

North America: the largest share of the genomics market

North America accounted for the largest share of the genomics market. Increasing government initiatives for promoting precision medicine, adoption of several strategies by key players to provide efficient genomics solutions in this region, and the presence of prominent players are the major drivers of the North American market.

Research Coverage

The report segments the genomics market based on region (Asia-Pacific, Europe, North America, and RoW), product & service (systems & software, consumables and services), technology (sequencing technologies, PCR, nucleic acid extraction and purification, microarrays, and other technologies), application (drug discovery and development, diagnostics, agriculture and animal research, and other applications), end user (hospitals & clinics, research centers and academic & government institutes, pharmaceutical & biotechnology companies, and other end users). The report also provides a comprehensive review of market drivers, opportunities, challenges and trends in the genomics market.

The genomics market is dominated by a few globally established players such as Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche (Switzerland), BGI (China), Eurofins Scientific (Germany), Oxford Nanopore Technologies (UK), Danaher Corporation (US), Merck KGaA (Germany), Eppendorf AG (Germany), Promega Corporation (US), Creative Biogene (US), New England Biolabs (US), Source BioScience (UK), Bionano Genomics (US), Macrogen, Inc. (South Korea), BioDiscovery (UK), Veritas Genetics International (US), and start-up companies such as 23andMe (US), Personalis (US), Novogene Co., Ltd. (China), Helix OpCo, LLC (US), Personal Genome Diagnostics Inc. (US), Phalanx Biotech Group (US), MedGenome (US), Resilient Biotics, Inc. (US), TruGenomix Health (US), and Cradle Genomics (US).

Breakdown of Primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

  • By Respondent: Supply Side - 80%, Demand Side - 20%
  • By Designation: CXOs - 20%, Executives - 25%, Mangers - 55%
  • By Region: North America - 30%, Europe - 20%, APAC - 40%, RoW - 10%

Key Benefits of Buying the Report

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the genomics market and provides them information on key market drivers, challenges, opportunities and trends.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 23Andme, Inc.
  • BGI
  • Danaher Corporation
  • Eurofins Scientific
  • Illumina, Inc.
  • New England Biolabs
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
1.7 Summary of Changes

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.1.3 Market Data Estimation and Triangulation
2.1.4 Data Triangulation
Figure 1 Data Triangulation Methodology
2.2 Market Estimation Methodology
Figure 2 Market Size Estimation: Approach 1 (Company Revenue Analysis-Based Estimation)
Figure 3 Genomics Market Size (USD Billion)
Figure 4 Genomics Market: Final CAGR Projections (2020-2025)
Figure 5 Genomics Market: CAGR Projections from the Analysis of Demand-Side Drivers, Opportunities, and Challenges
Figure 6 Genomics Market: Segmental Assessment
2.3 Industry Insights
2.4 Research Assumptions

3 Executive Summary
Figure 7 Genomics Market, by Product & Service, 2020 vs. 2025 (USD Billion)
Figure 8 Genomics Market Share, by Technology, 2019
Figure 9 Genomics Market, by Application, 2020 vs. 2025 (USD Billion)
Figure 10 Genomics Market, by End-user, 2020−2025
Figure 11 Geographical Snapshot of the Genomics Market

4 Premium Insights
4.1 Genomics Market Overview
Figure 12 Increasing Government Funding to Support Genomics Projects to Drive Market Growth
4.2 Asia-Pacific: Genomics Market, by Application & Country (2019)
Figure 13 Drug Discovery and Development Accounted for the Largest Share of the Asia-Pacific Market in 2019
4.3 Genomics Market for Sequencing, by Type
Figure 14 Next-Generation Sequencing Projected to Witness the Highest Growth in the Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 15 Genomics Market: Drivers, Opportunities, Challenges, and Trends
5.2.1 Drivers
5.2.1.1 Increasing Government Funding to Support Genomics Projects
5.2.1.2 Growing Incidence of Cancer and Increasing Applications of Next-Generation Sequencing in Cancer Research
Table 1 Global Cancer Incidence, 2020 vs. 2040
5.2.1.3 Entry of New Players and Start-Ups in the Genomics Market
5.2.1.4 Growing Application Areas of Genomics
5.2.2 Opportunities
5.2.2.1 Use of Genomics in Specialized/Personalized Medicine
5.2.3 Challenges
5.2.3.1 High Cost of Genomic Equipment
5.2.3.2 Dearth of Trained Professionals
5.2.3.3 Secure Storage of Large Volumes of Sequenced Data
5.2.4 Trends
5.2.4.1 Partnerships and Collaborations for Technological Advancements in Genomics
5.2.4.2 Impact of COVID-19 on the Genomics Market
5.3 Technological Analysis
Table 2 Comparison of Sanger Sequencing and NGS
5.4 Value Chain Analysis
Figure 16 Value Chain Analysis - Maximum Value is Added During the Sequencing and Analysis Phase
5.5 Regulatory Analysis
5.5.1 North America
5.5.1.1 US
Table 3 US FDA: Medical Device Classification
Table 4 US: Medical Device Regulatory Approval Process
5.5.2 Europe
Figure 17 Europe: Regulatory Approval Process for Medical Devices (MDR)
5.5.2.1 Asia-Pacific
5.5.2.1.1 China
Table 5 China: Classification of Medical Devices
5.6 Ecosystem Analysis of the Genomics Market
Figure 18 Ecosystem Analysis of the Genomics Market

6 Genomics Market, by Product & Service
6.1 Introduction
Table 6 Genomics Market, by Product & Service, 2018-2025 (USD Million)
6.2 Consumables
6.2.1 Consumables Form the Largest Product Segment of the Genomics Market
Table 7 Genomics Consumables Market, by Region, 2018-2025 (USD Million)
Table 8 Genomics Consumables Market, by Country, 2018-2025 (USD Million)
6.3 Systems & Software
6.3.1 Declining Rates of Genome Sequencing to Increase the Demand for Genomics Systems & Software
Table 9 Genomics Systems & Software Market, by Region, 2018-2025 (USD Million)
Table 10 Genomics Systems & Software Market, by Country, 2018-2025 (USD Million)
6.4 Services
6.4.1 High Cost of Genomic Instruments and the Possibility of Instrument Obsolescence Have Driven End-users to Outsource Their Sequencing Needs
Table 11 Genomics Services Market, by Region, 2018-2025 (USD Million)
Table 12 Genomics Services Market, by Country, 2018-2025 (USD Million)

7 Genomics Market, by Technology
7.1 Introduction
Table 13 Genomics Market, by Technology, 2018-2025 (USD Million)
7.2 Sequencing
7.2.1 Increasing Applications of Sequencing in Human Genomics to Drive Market Growth
Table 14 Genomics Market for Sequencing, by Region, 2018-2025 (USD Million)
Table 15 Genomics Market for Sequencing, by Country, 2018-2025 (USD Million)
Table 16 Genomics Market for Sequencing, by Type, 2018-2025 (USD Million)
7.3 PCR
7.3.1 PCR Allows Researchers to Produce Millions of Copies of a Specific DNA Sequence Within Hours
Table 17 Genomics Market for PCR, by Region, 2018-2025 (USD Million)
Table 18 Genomics Market for PCR, by Country, 2018-2025 (USD Million)
7.4 Nucleic Acid Extraction and Purification
7.4.1 Advances in Nucleic Acid Extraction and Purification Technologies are Expected to Support the Growth of this Market
Table 19 Genomics Market for Nucleic Acid Extraction and Purification, by Region, 2018-2025 (USD Million)
Table 20 Genomics Market for Nucleic Acid Extraction and Purification, by Country, 2018-2025 (USD Million)
7.5 Microarrays
7.5.1 High Adoption of NGS May Limit the Growth of Microarray Technologies in this Market to a Certain Extent
Table 21 Genomics Market for Microarrays, by Region, 2018-2025 (USD Million)
Table 22 Genomics Market for Microarrays, by Country, 2018-2025 (USD Million)
7.6 Other Technologies
Table 23 Genomics Market for Other Technologies, by Region, 2018-2025 (USD Million)
Table 24 Genomics Market for Other Technologies, by Country, 2018-2025 (USD Million)

8 Genomics Market, by Application
8.1 Introduction
Table 25 Genomics Market, by Application, 2018-2025 (USD Million)
8.2 Drug Discovery and Development
8.2.1 Drug Discovery and Development Forms the Largest Application Segment of the Genomics Market
Table 26 Genomics Market for Drug Discovery and Development Applications, by Region, 2018-2025 (USD Million)
Table 27 Genomics Market for Drug Discovery and Development Applications, by Country, 2018-2025 (USD Million)
8.3 Diagnostics
8.3.1 Growing Applications of Genomics in the Diagnostics Field to Propel Market Growth
Table 28 Grants, by Cancer Type (As of October 2020)
Table 29 Genomics Market for Diagnostic Applications, by Region, 2018-2025 (USD Million)
Table 30 Genomics Market for Diagnostic Applications, by Country, 2018-2025 (USD Million)
Table 31 Genomics Market for Diagnostic Applications, by Type, 2018-2025 (USD Million)
8.4 Agriculture and Animal Research
8.4.1 Genomics Helps in Improving the Productivity of Crops and Livestock - A Key Factor Driving Market Growth
Table 32 Genomics Market for Agriculture and Animal Research Applications, by Region, 2018-2025 (USD Million)
Table 33 Genomics Market for Agriculture and Animal Research Applications, by Country, 2018-2025 (USD Million)
8.5 Other Applications
Table 34 Genomics Market for Other Applications, by Region, 2018-2025 (USD Million)
Table 35 Genomics Market for Other Applications, by Country, 2018-2025 (USD Million)

9 Genomics Market, by End-user
9.1 Introduction
Table 36 Genomics Market, by End-user, 2018-2025 (USD Million)
9.2 Hospitals & Clinics
9.2.1 Increasing Demand for Pharmacogenomics to Drive the Acceptance of NGS in Hospitals
Table 37 Genomics Market for Hospitals & Clinics, by Region, 2018-2025 (USD Million)
Table 38 Genomics Market for Hospitals & Clinics, by Country, 2018-2025 (USD Million)
9.3 Research Centers and Academic & Government Institutes
9.3.1 Increase in Research Intensity to Drive the Usage of Genomics Products Among Academic & Government Institutes
Table 39 Genomics Market for Research Centers and Academic & Government Institutes, by Region, 2018-2025 (USD Million)
Table 40 Genomics Market for Research Centers and Academic & Government Institutes, by Country, 2018-2025 (USD Million)
9.4 Pharmaceutical & Biotechnology Companies
9.4.1 Growing Importance of Biomarkers to Drive the Use of Genomics Products & Services Among Pharma & Biotech Companies
Table 41 Genomics Market for Pharmaceutical & Biotechnology Companies, by Region, 2018-2025 (USD Million)
Table 42 Genomics Market for Pharmaceutical & Biotechnology Companies, by Country, 2018-2025 (USD Million)
9.5 Other End-users
Table 43 Genomics Market for Other End-users, by Region, 2018-2025 (USD Million)
Table 44 Genomics Market for Other End-users, by Country, 2018-2025 (USD Million)

10 Genomics Market, by Region
10.1 Introduction
Figure 19 North America Will Continue to Dominate the Genomics Market During the Forecast Period
Table 45 Genomics Market, by Region, 2018-2025 (USD Million)
10.2 North America
Figure 20 North America: Genomics Market Snapshot
Table 46 North America: Genomics Market, by Country, 2018-2025 (USD Million)
Table 47 North America: Genomics Market, by Product & Service, 2018-2025 (USD Million)
Table 48 North America: Genomics Market, by Technology, 2018-2025 (USD Million)
Table 49 North America: Genomics Market, by Application, 2018-2025 (USD Million)
Table 50 North America: Genomics Market, by End-user, 2018-2025 (USD Million)
10.2.1 US
10.2.1.1 US Dominates the North American Genomics Market
Table 51 US: Genomics Market, by Product & Service, 2018-2025 (USD Million)
Table 52 US: Genomics Market, by Technology, 2018-2025 (USD Million)
Table 53 US: Genomics Market, by Application, 2018-2025 (USD Million)
Table 54 US: Genomics Market, by End-user, 2018-2025 (USD Million)
10.2.2 Canada
10.2.2.1 Increasing Research in the Field of Genomics to Drive Market Growth
Table 55 Canada: Genomics Market, by Product & Service, 2018-2025 (USD Million)
Table 56 Canada: Genomics Market, by Technology, 2018-2025 (USD Million)
Table 57 Canada: Genomics Market, by Application, 2018-2025 (USD Million)
Table 58 Canada: Genomics Market, by End-user, 2018-2025 (USD Million)
10.3 Europe
Table 59 Europe: Genomics Market, by Country, 2018-2025 (USD Million)
Table 60 Europe: Genomics Market, by Product & Service, 2018-2025 (USD Million)
Table 61 Europe: Genomics Market, by Technology, 2018-2025 (USD Million)
Table 62 Europe: Genomics Market, by Application, 2018-2025 (USD Million)
Table 63 Europe: Genomics Market, by End-user, 2018-2025 (USD Million)
10.3.1 UK
10.3.1.1 Availability of Government Funding and Strategic Collaborations with Biotech Firms to Boost the Market
Table 64 UK: Genomics Market, by Product & Service, 2018-2025 (USD Million)
Table 65 UK: Genomics Market, by Technology, 2018-2025 (USD Million)
Table 66 UK: Genomics Market, by Application, 2018-2025 (USD Million)
Table 67 UK: Genomics Market, by End-user, 2018-2025 (USD Million)
10.3.2 Germany
10.3.2.1 Increasing Awareness of NGS in the Country to Boost the Market Growth in Germany
Table 68 Germany: Genomics Market, by Product & Service, 2018-2025 (USD Million)
Table 69 Germany: Genomics Market, by Technology, 2018-2025 (USD Million)
Table 70 Germany: Genomics Market, by Application, 2018-2025 (USD Million)
Table 71 Germany: Genomics Market, by End-user, 2018-2025 (USD Million)
10.3.3 France
10.3.3.1 Increasing Government Investments in Genomics to Boost the Growth of the French Genomics Market
Table 72 France: Genomics Market, by Product & Service, 2018-2025 (USD Million)
Table 73 France: Genomics Market, by Technology, 2018-2025 (USD Million)
Table 74 France: Genomics Market, by Application, 2018-2025 (USD Million)
Table 75 France: Genomics Market, by End-user, 2018-2025 (USD Million)
10.3.4 Roe
Table 76 Roe: Genomics Market, by Product & Service, 2018-2025 (USD Million)
Table 77 Roe: Genomics Market, by Technology, 2018-2025 (USD Million)
Table 78 Roe: Genomics Market, by Application, 2018-2025 (USD Million)
Table 79 Roe: Genomics Market, by End-user, 2018-2025 (USD Million)
10.4 Asia-Pacific
Figure 21 Asia-Pacific: Genomics Market Snapshot
Table 80 Asia-Pacific: Genomics Market, by Country, 2018-2025 (USD Million)
Table 81 Asia-Pacific: Genomics Market, by Product & Service, 2018-2025 (USD Million)
Table 82 Asia-Pacific: Genomics Market, by Technology, 2018-2025 (USD Million)
Table 83 Asia-Pacific: Genomics Market, by Application, 2018-2025 (USD Million)
Table 84 Asia-Pacific: Genomics Market, by End-user, 2018-2025 (USD Million)
10.4.1 China
10.4.1.1 China is Expected to Command the Largest Share of the Asia-Pacific Market
Table 85 China: Genomics Market, by Product & Service, 2018-2025 (USD Million)
Table 86 China: Genomics Market, by Technology, 2018-2025 (USD Million)
Table 87 China: Genomics Market, by Application, 2018-2025 (USD Million)
Table 88 China: Genomics Market, by End-user, 2018-2025 (USD Million)
10.4.2 Japan
10.4.2.1 Growing Conferences and Workshops on Newer Genomics Technologies Such as NGS to Increase Awareness and Drive the Market
Table 89 Japan: Genomics Market, by Product & Service, 2018-2025 (USD Million)
Table 90 Japan: Genomics Market, by Technology, 2018-2025 (USD Million)
Table 91 Japan: Genomics Market, by Application, 2018-2025 (USD Million)
Table 92 Japan: Genomics Market, by End-user, 2018-2025 (USD Million)
10.4.3 India
10.4.3.1 Emergence of Local Players & Increasing Adoption of Genomics Technologies is Expected to Aid the Growth of the Genomics Market in India
Table 93 India: Genomics Market, by Product & Service, 2018-2025 (USD Million)
Table 94 India: Genomics Market, by Technology, 2018-2025 (USD Million)
Table 95 India: Genomics Market, by Application, 2018-2025 (USD Million)
Table 96 India: Genomics Market, by End-user, 2018-2025 (USD Million)
10.4.4 Rest of Asia-Pacific
Table 97 RoAPAC: Genomics Market, by Product & Service, 2018-2025 (USD Million)
Table 98 RoAPAC: Genomics Market, by Technology, 2018-2025 (USD Million)
Table 99 RoAPAC: Genomics Market, by Application, 2018-2025 (USD Million)
Table 100 RoAPAC: Genomics Market, by End-user, 2018-2025 (USD Million)
10.5 Rest of the World
Table 101 RoW: Genomics Market, by Region, 2018-2025 (USD Million)
Table 102 RoW: Genomics Market, by Product & Service, 2018-2025 (USD Million)
Table 103 RoW: Genomics Market, by Technology, 2018-2025 (USD Million)
Table 104 RoW: Genomics Market, by Application, 2018-2025 (USD Million)
Table 105 RoW: Genomics Market, by End-user, 2018-2025 (USD Million)
10.5.1 Latin America
10.5.1.1 Expansions of Key Players in Latin American Regions to Boost the Market
Table 106 Latin America: Genomics Market, by Product & Service, 2018-2025 (USD Million)
Table 107 Latin America: Genomics Market, by Technology, 2018-2025 (USD Million)
Table 108 Latin America: Genomics Market, by Application, 2018-2025 (USD Million)
Table 109 Latin America: Genomics Market, by End-user, 2018-2025 (USD Million)
10.5.2 Middle East & Africa
10.5.2.1 Increasing Adoption of Genetic Testing in the Middle East and Rising HIV & Cancer Incidence in Africa are Driving Market Growth
Table 110 Middle East & Africa: Genomics Market, by Product & Service, 2018-2025 (USD Million)
Table 111 Middle East & Africa: Genomics Market, by Technology, 2018-2025 (USD Million)
Table 112 Middle East & Africa: Genomics Market, by Application, 2018-2025 (USD Million)
Table 113 Middle East & Africa: Genomics Market, by End-user, 2018-2025 (USD Million)

11 Competitive Landscape
11.1 Introduction
11.2 Market Share Analysis
Figure 22 Genomics Market Share Analysis, by Key Player, 2019
11.3 Market Evaluation Framework
Table 114 Market Evaluation Framework: Product & Service Launches - The Major Strategy Adopted by Players
11.4 Competitive Benchmarking
11.4.1 Analysis of the Product Portfolio of Major Players in the Genomics Market
11.5 Competitive Scenario
11.5.1 Key Product Launches
11.5.2 Key Collaborations, Partnerships, and Agreements
11.5.3 Key Expansions
11.5.4 Key Acquisitions
11.6 Company Evaluation Matrix
11.6.1 Global Genomics Market: Company Evaluation Matrix (Overall Market) (2019)
11.6.1.1 Stars
11.6.1.2 Emerging Leaders
11.6.1.3 Pervasive Players
11.6.1.4 Participants
Figure 23 Global Genomics Market: Company Evaluation Matrix, 2019
11.6.2 Competitive Leadership Mapping (Start-Ups) (2019)
11.6.2.1 Progressive Companies
11.6.2.2 Starting Blocks
11.6.2.3 Dynamic Companies
11.6.2.4 Responsive Companies
Figure 24 Competitive Leadership Mapping: Genomics Market

12 Company Profiles
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, Analyst's View)*
12.1 Major Players
12.1.1 Illumina, Inc.
Figure 25 Illumina, Inc.: Company Snapshot (2019)
12.1.2 Thermo Fisher Scientific, Inc.
Figure 26 Thermo Fisher Scientific, Inc.: Company Snapshot (2019)
12.1.3 Qiagen N.V.
Figure 27 Qiagen N.V.: Company Snapshot (2019)
12.1.4 Agilent Technologies
Figure 28 Agilent Technologies: Company Snapshot (2020)
12.1.5 F. Hoffmann-La Roche, Ltd.
Figure 29 F. Hoffmann-La Roche, Ltd.: Company Snapshot (2019)
12.1.6 Bio-Rad Laboratories, Inc.
Figure 30 Bio-Rad Laboratories, Inc.: Company Snapshot (2019)
12.1.7 Eurofins Scientific
Figure 31 Eurofins Scientific: Company Snapshot (2019)
12.1.8 Oxford Nanopore Technologies
12.1.9 BGI
12.1.10 Danaher Corporation
Figure 32 Danaher Corporation: Company Snapshot (2019)
12.1.11 Eppendorf AG
Figure 33 Eppendorf AG: Company Snapshot (2019)
12.1.12 Merck KGaA
Figure 34 Merck KGaA: Company Snapshot (2019)
12.1.13 New England Biolabs
12.1.14 Promega Corporation
12.1.15 Creative Biogene
12.1.16 Start-Up/SME Players
12.1.16.1 Novogene Co. Ltd.
12.1.16.2 Helix Opco, LLC
12.1.16.3 23Andme, Inc.
12.1.16.4 Personal Genome Diagnostics Inc. (PGDX)
12.1.16.5 Personalis, Inc.
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, Analyst's View Might Not be Captured in Case of Unlisted Companies

13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: The Subscription Portal
13.3 Available Customizations

Note: Product cover images may vary from those shown
  • 23Andme, Inc.
  • Agilent Technologies
  • BGI
  • Bio-Rad Laboratories, Inc.
  • Creative Biogene
  • Danaher Corporation
  • Eppendorf AG
  • Eurofins Scientific
  • F. Hoffmann-La Roche, Ltd.
  • Helix Opco, LLC
  • Illumina, Inc.
  • Merck KGaA
  • New England Biolabs
  • Novogene Co. Ltd.
  • Oxford Nanopore Technologies
  • Personal Genome Diagnostics Inc. (PGDX)
  • Personalis, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll